1. Home
  2. CRDL vs OVBC Comparison

CRDL vs OVBC Comparison

Compare CRDL & OVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDL
  • OVBC
  • Stock Information
  • Founded
  • CRDL 2017
  • OVBC 1872
  • Country
  • CRDL Canada
  • OVBC United States
  • Employees
  • CRDL N/A
  • OVBC N/A
  • Industry
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • OVBC Major Banks
  • Sector
  • CRDL Health Care
  • OVBC Finance
  • Exchange
  • CRDL Nasdaq
  • OVBC Nasdaq
  • Market Cap
  • CRDL 142.5M
  • OVBC 114.0M
  • IPO Year
  • CRDL N/A
  • OVBC N/A
  • Fundamental
  • Price
  • CRDL $1.58
  • OVBC $27.84
  • Analyst Decision
  • CRDL Strong Buy
  • OVBC
  • Analyst Count
  • CRDL 3
  • OVBC 0
  • Target Price
  • CRDL $9.00
  • OVBC N/A
  • AVG Volume (30 Days)
  • CRDL 421.9K
  • OVBC 3.6K
  • Earning Date
  • CRDL 11-14-2024
  • OVBC 10-28-2024
  • Dividend Yield
  • CRDL N/A
  • OVBC 3.29%
  • EPS Growth
  • CRDL N/A
  • OVBC N/A
  • EPS
  • CRDL N/A
  • OVBC 2.46
  • Revenue
  • CRDL N/A
  • OVBC $57,340,000.00
  • Revenue This Year
  • CRDL N/A
  • OVBC N/A
  • Revenue Next Year
  • CRDL N/A
  • OVBC N/A
  • P/E Ratio
  • CRDL N/A
  • OVBC $11.21
  • Revenue Growth
  • CRDL N/A
  • OVBC 3.72
  • 52 Week Low
  • CRDL $0.79
  • OVBC $19.35
  • 52 Week High
  • CRDL $3.12
  • OVBC $27.95
  • Technical
  • Relative Strength Index (RSI)
  • CRDL 30.69
  • OVBC 74.60
  • Support Level
  • CRDL $1.83
  • OVBC $24.20
  • Resistance Level
  • CRDL $1.92
  • OVBC $25.51
  • Average True Range (ATR)
  • CRDL 0.15
  • OVBC 0.85
  • MACD
  • CRDL -0.04
  • OVBC 0.34
  • Stochastic Oscillator
  • CRDL 12.00
  • OVBC 97.97

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services within Southeastern Ohio as well as western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers and other standard banking products and services. The bank segmented its operating activities into two reportable segments, Banking and Consumer Finance. The majority of its total revenue is derived from the Banking segment.

Share on Social Networks: